Involvement of estrogen receptors in prostatic diseases

International Journal of Urology

Volumn 19, Issue 6, 2012, Pages 512-522

  Kawashima, Hidenori ^a   Nakatani, Tatsuya ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Benign prostatic hyperplasia; Estrogen receptors and ; Pathogenesis; Prostate cancer; Therapeutic target

Indexed keywords

2 [4 (2 PIPERIDINOETHOXY)PHENYL] 3 PHENYL 2H 1 BENZOPYRAN; BIOCHANIN A; CENTCHROMAN; DOCETAXEL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR RELATED RECEPTOR; FINASTERIDE; FULVESTRANT; GENISTEIN; ISOFLAVONE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PLACEBO; QUERCETIN; RALOXIFENE; RECEPTOR; TAMOXIFEN; TOREMIFENE; UNCLASSIFIED DRUG;

BINDING SITE; CARCINOGENESIS; CASTRATION RESISTANT PROSTATE CANCER; CELL MATURATION; CELL PROLIFERATION; DRUG TARGETING; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SPLICING DEFECT;

HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ESTROGEN;

EID: 84861480333     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2012.02987.x     Document Type: Review

References (87)

1. Prins GS, Huang L, Birch L, Pu Y. The role of estrogens in normal and abnormal development of the prostate gland. Ann. N. Y. Acad. Sci. 2006; 1089: 1-13.
2. Prins GS, Korach KS. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 2008; 73: 233-44.
3. Noble RL. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res. 1977; 37: 1929-33.
4. Kuiper GG, Enmark E, Pelt-Huikko M, Nilsson S, Gustafsson J-A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 5925-30.
5. Chang WY, Prins GS. Estrogen receptor β: implication for the prostate gland. Prostate 1999; 40: 115-24.
6. Lau K-M, LaSpina M, Long J, Ho S-M. Expression of estrogen receptor (ER)-α and ER-β in normal and malignant prosratic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res. 2000; 60: 3175-82.
7. Latil A, Bieche I, Vidaud D etal. Evaluation of androgen, estrogen (ERα and ERβ), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res. 2001; 61: 1919-26.
8. Royuela M, de Miguel MP, Bethencourt FR etal. Estrogen receptors α and β in the normal, hyperplastic and carcinomatous human prostate. J. Endocrinol. 2001; 168: 447-54.
9. Tsurusaki T, Aoki D, Kanetake H etal. Zone-dependent expression of estrogen receptors α and β in human benign prostatic hyperplasia. J. Clin. Endocrinol. Metab. 2003; 88: 1333-40.
10. Linja MJ, Savinainen KJ, Tammela TL, Isola JJ, Visakorpi T. Expression of ERα and ERβ in prostate cancer. Prostate 2003; 55: 180-6.
11. Weihua Z, Warner M, Gustafsson JA. Estrogen receptor beta in the prostate. Mol. Cell. Endocrinol. 2002; 193: 1-5.
12. Bosland MC. The role of estrogens in prostate carcinogenesis: a rationale for chemoprevention. Rev. Urol. 2005; 7 (Suppl 3): S4-10.
13. Ho CK, Habib FK. Estrogen and androgen signaling in the pathogenesis of BPH. Nat. Rev. Urol. 2011; 8: 29-41.
14. Bonkhoff H, Berges R. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. Eur. Urol. 2009; 55: 533-42.
15. Leav I, Lau K-M, Adams JY etal. Comparative studies of the estrogen receptors β and α and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am. J. Pathol. 2001; 159: 79-92.
16. Fixemer T, Remberger K, Bonkhoff H. Differential expression of the estrogen receptor β (ERβ) in human prostate tissue, premalignant changes, and in primary, metastatic and recurrent prostatic adenocarcinoma. Prostate 2003; 54: 79-87.
17. Torlakovic E, Lilleby W, Torlakovic G, Fossa SD, Chibber R. Prostate carcinoma expression of estrogen receptor-β as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score. Hum. Pathol. 2002; 33: 646-51.
18. Walton TJ, Li G, McCulloch TA etal. Quantitative RT-PCR analysis of estrogen receptor gene expression in Laser microdissected prostate cancer tissue. Prostate 2009; 69: 810-19.
19. Imamiv O, Morani A, Shim G-J etal. Estrogen receptor β regulates epithelial cellular differentiation in the mouse ventral prostate. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 9375-80.
20. Griffiths K, Denis LJ, Behre HE etal. Estrogens and prostatic disease. Prostate 2000; 45: 87-100.
21. King KJ, Nicholson HD, Assinder SJ. Effect of increasing ratio of estrogen:androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP. Prostate 2006; 66: 105-14.
22. Zhang Z, Duan L, Du X, Ma H, Park I, Lee C. The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK. Prostate 2008; 68: 508-16.
23. Nomura H, Kawashima H, Masaki S etal. Effect of selective estrogen receptor modulators on cell proliferation and estrogen receptor activities in normal human prostate stromal and epithelial cells. Prostate Cancer Prostatic Dis. 2009; 12: 375-81.
24. Krill D, Shuman M, Thompson MT, Becich MJ, Strom SC. A simple method for the isolation and culture of epithelial and stromal cells from benign and neoplastic prostates. Urology 1997; 49: 981-8.
25. Peehl DM. Primary cell cultures as models of prostate cancer development. Endocr. Relat. Cancer 2005; 12: 19-47.
26. Peehl DM, Sellers RG. Cultured stromal cells: an in vitro model of prostatic mesenchymal biology. Prostate 2000; 45: 115-23.
27. Planz B, Kirley SD, Wang Q, Tabatabaei S, Aretz HT, McDougal WS. Characterization of a stromal cell model of the human benign and malignant prostate from explant culture. J. Urol. 1999; 161: 1329-36.
28. Janßen M, Albrecht M, Möschler O etal. Cell lineage characteristics of human prostatic stromal cells cultured in vitro. Prostate 2000; 43: 20-30.
29. Tran CP, Lin C, Yamashiro J, Reiter RE. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol. Cancer Res. 2002; 1: 113-21.
30. Garraway LA, Lin D, Signoretti S etal. Intermediate basal cells of the prostate: in vitro and in vivo characterization. Prostate 2003; 55: 206-18.
31. Ho CKM, Nanda J, Chapman KE, Habib FK. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen. J. Endocrinol. 2008; 197: 483-91.
32. Zhou D, Li S, Wang X, Cheng B, Ding W. Estrogen receptor alpha is essential for the proliferation of prostatic smooth muscle cells stimulated by 17β-estradiol and insulin-like growth factor 1. Cell Biochem. Funct. 2011; 29: 120-5.
33. Chen M, Hsu I, Wolfe A etal. Defects of prostate development and reproductive system in the estrogen receptor-α null male mice. Endocrinology 2009; 150: 251-9.
34. Bonkhoff H, Fixemer T, Hunsicker I, Remberger K. Estrogen receptor expression in prostate cancer and premalignant prostatic lesions. Am. J. Pathol. 1999; 155: 641-7.
35. Bonkhoff H, Fixemer T, Hunsicker I, Remberger K. Progesterone receptor expression in human prostate cancer: correlation with tumor progression. Prostate 2001; 48: 285-91.
36. Hu W-Y, Shi G-B, Lam H-M etal. Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells. Endocrinology 2011; 152: 2150-63.
37. Singh PB, Matanhelia SS, Martin FL. A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver. Eur. J. Cancer 2008; 44: 928-36.
38. Ricke WA, McPherson SJ, Bianco JJ, Cunha GR, Wang Y, Risbridger GP. Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J. 2008; 22: 1512-20.
39. Setlur SR, Mertz KD, Hoshida Y etal. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J. Natl. Cancer Inst. 2008; 100: 815-25.
40. Watanabe T, Inoue S, Hiroi H, Orimo A, Kawashima H, Muramatsu M. Isolation of estrogen-responsive gene with a CpG island library. Mol. Cell. Biol. 1998; 18: 442-9.
41. Takahashi S, Urano T, Tsuchiya F etal. EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer. Int. J. Cancer 2003; 106: 310-15.
42. Yu L, Wang C-Y, Shi J etal. Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells. Endocrinology 2011; 152: 773-81.
43. Nicolaiew N, Cancel-Tassin G, Azzouzi AR etal. Association between estrogen and androgen receptor genes and prostate cancer risk. Eur. J. Endocrinol. 2009; 160: 101-6.
44. Sonoda T, Suzuki H, Mori M etal. Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men. Eur. J. Cancer Prev. 2010; 19: 131-7.
45. Horvath LG, Henshall SM, Lee C-S etal. Frequent loss of estrogen receptor-β expression in prostate cancer. Cancer Res. 2001; 61: 5331-5.
46. Hurtado A, Pinos T, Barbosa-Desongles A etal. Estrogen receptor beta displays cell cycle-dependent expression and regulates the G1 phase through a non-genomic mechanism in prostate carcinoma cells. Cell 2008; 30: 349-65.
47. Walton TJ, Li G, Seth R, McArdle ES, Bishop MC, Rees RC. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines. Prostate 2008; 68: 210-22.
48. Cheng J, Lee EJ, Madison LD, Lazennec G. Expression of estrogen receptor β in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett. 2004; 566: 169-72.
49. Rossi V, Bellastella G, De Losa C etal. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β. J. Cell. Physiol. 2011; 226: 1334-9.
50. Leung Y-K, Gao Y, Lau K-M, Zhang X, Ho S-M. ICI 182780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-β/NFκB crosstalk. Neoplasia 2006; 8: 242-9.
51. Matsumura K, Tanaka T, Kawashima H, Nakatani T. Involvement of the estrogen receptor β in genistein-induced expression of p21 waf1/cip1 in PC-3 prostate cancer cells. Anticancer Res. 2008; 28: 709-14.
52. Weihua Z, Makela S, Andersson LC etal. A role for estrogen receptor β in the regulation of growth of the ventral prostate. Proc. Natl. Acad. Sci. U.S.A. 2001; 98: 6330-5.
53. Antal MC, Krust A, Chambon P, Mark M. Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERβ-null mutant. Proc. Natl. Acad. Sci. U.S.A. 2008; 105: 2433-8.
54. McPherson SJ, Wang H, Jones ME etal. Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology 2001; 142: 2458-67.
55. McPherson SJ, Ellem SJ, Simpson ER, Patchev V, Fritzemeier KH, Risbridger GP. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology 2007; 148: 566-74.
56. Risbridger GP, Ellem SJ, McPherson SJ. Estrogen action on the prostate gland: a critical mix of endocrine and paracrine signaling. J. Mol. Endocrinol. 2007; 39: 183-8.
57. Paech K, Webb P, Kuiper GGJM etal. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 1997; 277: 1508-10.
58. Nakajima Y, Akaogi K, Suzuki T etal. Estrogen regulates tumor growth through a non-classical pathway that includes the transcription factors ERβ and KLF5. Sci. Signal. 2011; 4: ra22.
59. Leung Y-K, Ho S-M. Estrogen receptor β: switching to a new partner and escaping from estrogen. Sci. Signal. 2011; 4: pe19.
60. Weihua Z, Warner M, Gustafsson J-A. Estrogen receptor beta in prostate. Mol. Cell. Endocrinol. 2002; 193: 1-5.
61. Sugiyama N, Barros RPA, Warner M, Gustafsson J-A. ERβ: recent understanding of estrogen signaling. Trends Endocrinol. Metab. 2010; 21: 545-52.
62. Dondi D, Piccolella M, Biserni A etal. Estrogen receptor β and the progression of prostate cancer: role of 5α-androstane-3β, 17β-diol. Endocr. Relat. Cancer 2010; 17: 731-42.
63. Guerini V, Sau D, Scaccianoce E etal. The androgen derivative 5α-androstane-3β, 17β-diol inhibits prostate cancer cell migration through activation of the estrogen receptor β subtype. Cancer Res. 2005; 65: 5445-53.
64. Mak P, Leav I, Pursell B etal. ERβ impedes prostate cancer EMT by destabilizing HIF-1α and inhibiting VEGF-mediated Snail nuclear localization: implications for Gleason grading. Cancer Cell. 2010; 17: 319-32.
65. McPherson SJ, Hussain S, Balanathan P etal. Estrogen receptor-β activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFα mediated. Proc. Natl. Acad. Sci. U.S.A. 2010; 107: 3123-8.
66. Moore JT, McKee DD, Slentz-Kesler K etal. Cloning and characterization of human estrogen receptor beta isoforms. Biochem. Biophys. Res. Commun. 1998; 247: 75-8.
67. Lewandowski S, Kalita K, Kaczmarek L. Minireview. Estrogen receptor β: potential functional significance of a variety of mRNA isoforms. FEBS Lett. 2002; 524: 1-5.
68. Leung YK, Mak P, Hassan S, Ho SM. Estrogen receptor (ER)-beta isoforms: a key to understand ER-beta signaling. Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 13162-7.
69. Ogawa S, Inoue S, Watanabe T etal. Molecular cloning and characterization of human estrogen receptor βcx: a potential inhibitor of estrogen action in human. Nucleic Acids Res. 1998; 26: 3505-12.
70. Fujimura T, Takahashi S, Urano T etal. Differential expression of estrogen receptor β (ERβ) and its C-terminal truncated splice variant ERβcx as prognostic predictors in human prostatic cancer. Biochem. Biophys. Res. Commun. 2001; 289: 692-9.
71. Leung Y-K, Lam H-M, Wu S etal. Estrogen receptor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Endocr. Relat. Cancer 2010; 17: 675-89.
72. Tremblay AM, Giguere V. The NR3B subgroup: an ovERRview. Nucl. Recept. Signal. 2007; 5: e009.
73. Giguere V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr. Rev. 2008; 29: 677-96.
74. Teyssier C, Bianco S, Lanvin O, Vanacker JM. The orphan receptor ERRα interferes with steroid signaling. Nucleic Acids Res. 2008; 36: 5350-61.
75. Duellman SJ, Calaoagan JM, Sato BG etal. A novel steroidal inhibitor of estrogen-related receptor α (ERRα). Biochem. Pharmacol. 2010; 80: 819-26.
76. Fujimura T, Takahashi S, Urano T etal. Increased expression of estrogen-related receptor α (ERRα) is a negative prognostic predictor in human prostate cancer. Int. J. Cancer 2007; 120: 2325-30.
77. Fujimura T, Takahashi S, Urano T etal. Differential expression of estrogen-related receptors β and γ (ERRβ and ERRγ) and their clinical significance in human prostate cancer. Cancer Sci. 2010; 101: 646-51.
78. Sissung TM, Danesi R, Kirkland CT etal. Estrogen receptor α and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy. J. Clin. Endocrinol. Metab. 2011; 96: E368-72.
79. Celhay O, Yacoub M, Irani J, Dore B, Cussenot O, Fromont G. Expression of estrogen related proteins in hormone refractory prostate cancer: association with tumor progression. J. Urol. 2010; 184: 2172-8.
80. Von Löw EC, Perabo FG, Siener R, Müller SC. Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data. In Vivo 2007; 21: 189-204.
81. Khan N, Adhami VM, Mukhtar H. Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr. Relat. Cancer 2010; 17: R39-52.
82. Bektic J, Berger AP, Pfeil K, Dobler G, Bartsch G, Klocker H. Androgen receptor regulation by physiological concentration of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta. Eur. Urol. 2004; 45: 245-51.
83. Kumar R, Verma V, Jain A etal. Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer. J. Nutr. Biochem. 2011; 8: 723-31.
84. Miyanaga N, Akaza H, Hinotsu S etal. Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen. Cancer Sci. 2012; 103: 125-30.
85. Price D, Stein B, Sieber P etal. Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled phase IIB clinical trial. J. Urol. 2006; 176: 965-70.
86. Raghow S, Hooshdaran MZ, Katiyar S, Steiner MS. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model. Cancer Res. 2002; 62: 1370-6.
87. Kumar R, Verma V, Sarswat A etal. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms: action of two new agents. Invest. 2012; 30: 582-93.